Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics

Elliot J. Coups, Sharon L. Manne, Pamela Ohman Strickland, Michelle Hilgart, James S. Goydos, Carolyn J. Heckman, P. Chamorro, Babar K. Rao, M. Davis, Franz O. Smith, Frances P. Thorndike, L. M. Ritterband

Research output: Contribution to journalArticle

Abstract

>1.2 million people in the United States have a personal history of melanoma skin cancer and are at increased risk for disease recurrence and second primary melanomas. Many of these individuals do not follow recommendations to conduct regular, thorough skin self-examinations that facilitate early disease detection and do not sufficiently engage in sun protection behaviors. In this project, we are conducting a randomized controlled trial of an innovative, tailored, theory-driven Internet intervention—called mySmartSkin—to promote these behaviors among melanoma patients. This paper outlines the study design and characteristics of the study sample. A total of 441 patients were recruited (40.9% response rate) and randomized to the mySmartSkin or a Usual Care condition. Participants complete surveys at baseline and 8 weeks, 24 weeks, and 48 weeks later. The primary aim of the project is to examine the impact of mySmartSkin versus Usual Care on skin self-examination and sun protection behaviors. The secondary aim focuses on identifying mediators of the intervention's effects. In an exploratory aim, we will examine potential moderators of the impact of the intervention. At baseline, the recruited participants had a mean age of 61 years, 49% were female, 7.5% met criteria for having conducted a recent, thorough skin self-examination, and the mean score on the index of sun protection behaviors was 3.3 (on a scale from 1 to 5). The results of the project will determine whether the mySmartSkin intervention is efficacious in promoting skin self-examination and sun protection behaviors among individuals diagnosed with melanoma. Trial registration: ClinicalTrials.gov NCT03028948

Original languageEnglish (US)
Pages (from-to)117-127
Number of pages11
JournalContemporary Clinical Trials
Volume83
DOIs
StatePublished - Aug 1 2019

Fingerprint

Self-Examination
Solar System
Melanoma
Randomized Controlled Trials
Skin
Skin Care
Skin Neoplasms
Internet
Early Diagnosis
Recurrence

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Keywords

  • Intervention
  • Melanoma
  • Prevention
  • Skin cancer
  • Skin self-examination
  • Sun protection

Cite this

@article{61dbf237d20f40768faadea78094bf56,
title = "Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics",
abstract = ">1.2 million people in the United States have a personal history of melanoma skin cancer and are at increased risk for disease recurrence and second primary melanomas. Many of these individuals do not follow recommendations to conduct regular, thorough skin self-examinations that facilitate early disease detection and do not sufficiently engage in sun protection behaviors. In this project, we are conducting a randomized controlled trial of an innovative, tailored, theory-driven Internet intervention—called mySmartSkin—to promote these behaviors among melanoma patients. This paper outlines the study design and characteristics of the study sample. A total of 441 patients were recruited (40.9{\%} response rate) and randomized to the mySmartSkin or a Usual Care condition. Participants complete surveys at baseline and 8 weeks, 24 weeks, and 48 weeks later. The primary aim of the project is to examine the impact of mySmartSkin versus Usual Care on skin self-examination and sun protection behaviors. The secondary aim focuses on identifying mediators of the intervention's effects. In an exploratory aim, we will examine potential moderators of the impact of the intervention. At baseline, the recruited participants had a mean age of 61 years, 49{\%} were female, 7.5{\%} met criteria for having conducted a recent, thorough skin self-examination, and the mean score on the index of sun protection behaviors was 3.3 (on a scale from 1 to 5). The results of the project will determine whether the mySmartSkin intervention is efficacious in promoting skin self-examination and sun protection behaviors among individuals diagnosed with melanoma. Trial registration: ClinicalTrials.gov NCT03028948",
keywords = "Intervention, Melanoma, Prevention, Skin cancer, Skin self-examination, Sun protection",
author = "Coups, {Elliot J.} and Manne, {Sharon L.} and {Ohman Strickland}, Pamela and Michelle Hilgart and Goydos, {James S.} and Heckman, {Carolyn J.} and P. Chamorro and Rao, {Babar K.} and M. Davis and Smith, {Franz O.} and Thorndike, {Frances P.} and Ritterband, {L. M.}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.cct.2019.06.014",
language = "English (US)",
volume = "83",
pages = "117--127",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",

}

Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma : study design and baseline characteristics. / Coups, Elliot J.; Manne, Sharon L.; Ohman Strickland, Pamela; Hilgart, Michelle; Goydos, James S.; Heckman, Carolyn J.; Chamorro, P.; Rao, Babar K.; Davis, M.; Smith, Franz O.; Thorndike, Frances P.; Ritterband, L. M.

In: Contemporary Clinical Trials, Vol. 83, 01.08.2019, p. 117-127.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma

T2 - study design and baseline characteristics

AU - Coups, Elliot J.

AU - Manne, Sharon L.

AU - Ohman Strickland, Pamela

AU - Hilgart, Michelle

AU - Goydos, James S.

AU - Heckman, Carolyn J.

AU - Chamorro, P.

AU - Rao, Babar K.

AU - Davis, M.

AU - Smith, Franz O.

AU - Thorndike, Frances P.

AU - Ritterband, L. M.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - >1.2 million people in the United States have a personal history of melanoma skin cancer and are at increased risk for disease recurrence and second primary melanomas. Many of these individuals do not follow recommendations to conduct regular, thorough skin self-examinations that facilitate early disease detection and do not sufficiently engage in sun protection behaviors. In this project, we are conducting a randomized controlled trial of an innovative, tailored, theory-driven Internet intervention—called mySmartSkin—to promote these behaviors among melanoma patients. This paper outlines the study design and characteristics of the study sample. A total of 441 patients were recruited (40.9% response rate) and randomized to the mySmartSkin or a Usual Care condition. Participants complete surveys at baseline and 8 weeks, 24 weeks, and 48 weeks later. The primary aim of the project is to examine the impact of mySmartSkin versus Usual Care on skin self-examination and sun protection behaviors. The secondary aim focuses on identifying mediators of the intervention's effects. In an exploratory aim, we will examine potential moderators of the impact of the intervention. At baseline, the recruited participants had a mean age of 61 years, 49% were female, 7.5% met criteria for having conducted a recent, thorough skin self-examination, and the mean score on the index of sun protection behaviors was 3.3 (on a scale from 1 to 5). The results of the project will determine whether the mySmartSkin intervention is efficacious in promoting skin self-examination and sun protection behaviors among individuals diagnosed with melanoma. Trial registration: ClinicalTrials.gov NCT03028948

AB - >1.2 million people in the United States have a personal history of melanoma skin cancer and are at increased risk for disease recurrence and second primary melanomas. Many of these individuals do not follow recommendations to conduct regular, thorough skin self-examinations that facilitate early disease detection and do not sufficiently engage in sun protection behaviors. In this project, we are conducting a randomized controlled trial of an innovative, tailored, theory-driven Internet intervention—called mySmartSkin—to promote these behaviors among melanoma patients. This paper outlines the study design and characteristics of the study sample. A total of 441 patients were recruited (40.9% response rate) and randomized to the mySmartSkin or a Usual Care condition. Participants complete surveys at baseline and 8 weeks, 24 weeks, and 48 weeks later. The primary aim of the project is to examine the impact of mySmartSkin versus Usual Care on skin self-examination and sun protection behaviors. The secondary aim focuses on identifying mediators of the intervention's effects. In an exploratory aim, we will examine potential moderators of the impact of the intervention. At baseline, the recruited participants had a mean age of 61 years, 49% were female, 7.5% met criteria for having conducted a recent, thorough skin self-examination, and the mean score on the index of sun protection behaviors was 3.3 (on a scale from 1 to 5). The results of the project will determine whether the mySmartSkin intervention is efficacious in promoting skin self-examination and sun protection behaviors among individuals diagnosed with melanoma. Trial registration: ClinicalTrials.gov NCT03028948

KW - Intervention

KW - Melanoma

KW - Prevention

KW - Skin cancer

KW - Skin self-examination

KW - Sun protection

UR - http://www.scopus.com/inward/record.url?scp=85068803133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068803133&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2019.06.014

DO - 10.1016/j.cct.2019.06.014

M3 - Article

C2 - 31255801

AN - SCOPUS:85068803133

VL - 83

SP - 117

EP - 127

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

ER -